Stockreport

Lyell Immunopharma Inc (LYEL) Reports 2023 Financial Results and Business Highlights [Yahoo! Finance]

Lyell Immunopharma, Inc.  (LYEL) 
PDF Revenue : Revenue was approximately zero for Q4 and $0.1 million for the full year 2023, following the termination of the GSK Agreement. R&D Expenses : R&D expenses i [Read more]